Antiparasitic Resistance in Cattle and Small Ruminants in the United States: How to Detect It and What to Do About It

Total Page:16

File Type:pdf, Size:1020Kb

Antiparasitic Resistance in Cattle and Small Ruminants in the United States: How to Detect It and What to Do About It Helpful Information for Veterinarians Antiparasitic Resistance in Cattle and Small Ruminants in the United States: How to Detect It and What to Do About It Introduction • Parasites in untreated animals, called host- based refugia. Internal parasite infections and external parasite infestations harm animal health and can result in • Eggs and larvae already on the pasture when significant production losses in food-producing the animals are treated, called environmental species, such as cattle, sheep, and goats. refugia. Antiparasitic animal drugs are used to treat and • Life stages of the parasite that are unaffected control parasitic infections and infestations in animals. by drug treatment, such as some larval stages. The parasites that a given drug is effective against are listed in the indication on the drug’s label. Why is preserving refugia important? Antiparasitic resistance is the genetic ability of Preserving refugia maintains drug-sensitive parasites to survive the effects of an antiparasitic drug (susceptible) parasites. The presence of some drug- to which they were previously susceptible. Antiparasitic sensitive parasites decreases (dilutes) the proportion resistance becomes a problem when an increasing of resistant parasites within the parasite population on percentage of a parasite population carries resistance a farm. genes, allowing the parasites to survive treatment with an antiparasitic drug that has been effective in the past. The Importance of Preserving Refugia Australia, New Zealand, South Africa, and South America have struggled with antiparasitic resistance in Parasite population within Parasite population within livestock species for the past few decades. Recent the herd: the herd: scientific data indicate antiparasitic resistance is now emerging in livestock species in the United States. Refugia After an animal is treated with an antiparasitic drug, the susceptible parasites die and the resistant Treat entire herd, so no Treat only 50% herd, so parasites survive to pass on resistance genes to their refugia is preserved. some refugia is preserved. offspring. If not enough susceptible parasites remain in the environment and in the animal, they cannot dilute the increase in resistant parasites that occurs after treatment. This scenario occurs when there is a lack of refugia. What is refugia? All susceptible parasites Some susceptible parasites die. Only resistant parasites remain to dilute the Refugia is the proportion of the total parasite remain to breed and pass resistant parasites, slowing population that is not selected for antiparasitic drug on resistance genes to their the development of a fully offspring. resistant parasite treatment—essentially, those parasites that are in population. “refuge” from the drug. Therefore, there's no selection pressure on these parasites to develop resistance. Key: Refugia maintains a proportion of susceptible Resistant parasite Susceptible parasite parasites on the farm and includes: 1 presence of antiparasitic resistance may Factors Contributing to Antiparasitic worsen the resistance. Resistance Relying solely on antiparasitic drugs to Parasite biology, genetics, and control parasites, rather than changing pathogenicity. management practices: using only drugs instead of incorporating methods to Immune status of the host animal. preserve refugia and better manage the pasture can speed up antiparasitic Treatment factors, such as dose and resistance. frequency of dosing. Using antiparasitic drugs for unapproved Drug factors, such as mechanism of uses, such as to increase weight gain: in action and half-life. the short-term, this may improve profitability; however, using antiparasitic Certain livestock drugs for unapproved uses increases the opportunities to eliminate management practices. susceptible parasites, leaving Newly hatched strongyle larvae. Photo courtesy of only resistant parasites Livestock Management Dr. Ray Kaplan, College of Veterinary Medicine, behind. In the long-term, this Practices Contributing University of Georgia. may lead to significant to Antiparasitic economic losses due to the Resistance negative effects of antiparasitic resistance on Treating every animal herd health. in the herd: treating the entire herd Detecting eliminates susceptible Antiparasitic parasites from all Resistance animals at once, increasing the Currently, the most common proportion of resistant on-the-farm test to detect parasites in the antiparasitic resistance is the population. Fecal Egg Count Reduction Test (FECRT). The FECRT is the only practical, widely Frequent routine deworming without available test to evaluate the effectiveness of performing diagnostic tests or antiparasitic drugs in the field. determining if treatment is necessary: treating animals too often increases the How the test works – opportunities to eliminate susceptible parasites, leaving only resistant parasites Fecal samples are collected from a proportion of behind. animals in a herd just before treatment with an antiparasitic drug and again after treatment Deworming when environmental refugia is (usually 14 days, but varies depending on the low: treating animals when there are few drug). Parasite eggs are counted in both the pre- eggs on the pasture, such as after a and post-treatment fecal samples. If the egg harsh winter or hot, dry summer, numbers in the post-treatment sample are not increases the proportion of resistant eggs reduced by at least 90 percent, resistance may in the environment. be present in the herd. Ninety percent has been the historical numerical value used to detect Giving an antiparasitic drug without resistance based on FECRT results. knowing if it will be effective on the farm: treating with less effective drugs in the Because the level of antiparasitic resistance varies from farm to farm, not all farms will have 2 the same percentage reduction in post-treatment Anemia in a goat due to egg counts after treatment with the same Haemonchus contortus antiparasitic drug. One farm may show a 98 (barber pole worm), as percent reduction while a neighboring farm may detected by assessing the color of the inner have a 91 percent reduction. For this reason, lower eyelid. Photo percentage reductions in post-treatment egg courtesy of Dr. Ray counts should be compared over time on the Kaplan, College of same farm. Veterinary Medicine, University of Georgia. If repeated FECRTs on the same farm show a consistent decrease in percentage reduction (for example, 98 percent reduction→96 percent Currently, these tests have some limitations, reduction→91 percent reduction), resistance mainly high cost. Also, the Egg Hatch Test and may be developing, even if the values are over LDA are only available for specific antiparasitic 90 percent. drugs. The FECRT is most accurate in sheep and goats. Other ancillary tests used to Several biological factors in cattle affect the determine if treatment with an sensitivity of the FECRT, including: antiparasitic drug is necessary and to Cattle shed fewer parasite eggs as they identify which parasites are present: age. FAMACHA© Eye Color Chart Scores Cattle-specific parasites generally On-the-farm test only for sheep and reproduce less frequently and produce goats that evaluates an animal’s load less offspring than small ruminant- of Haemonchus contortus (barber pole specific parasites. worm). Worm load is associated with the color of the inner lower eyelid Cattle manure has a higher water content which correlates to the degree of than small ruminant manure. The water anemia. dilutes the concentration of parasite eggs, resulting in fewer eggs per fecal Coproculture sample. Identifies the parasites that are Other tests to detect antiparasitic resistance are present in a herd. available only through select laboratories: How the test works – Polymerase Chain Reaction (PCR) Test Genetically identifies resistant Fecal samples are collected and parasites. cultured from select animals in a herd. The parasite eggs hatch and the larvae Egg Hatch Test are identified to the species level. Evaluates resistance to Managing Antiparasitic Resistance benzimidazoles. To slow the development of antiparasitic resistance on a farm, encourage producers to Larval Development Assay (LDA) use antiparasitic drugs as just one part of an overall parasite control program that fits the Evaluates in vitro resistance to needs of their herd. benzimidazoles, levamisole, and some macrocyclic lactones. 3 Tips for managing antiparasitic resistance: Use management practices along with antiparasitic drugs to treat and control Use clinical signs and diagnostic test parasites. Some good management results to determine which parasites are practices include: present on the farm, as well as to determine the level of infection and level Preserving refugia within the herd. of resistance. Base management and treatment decisions on this information. Quarantining new livestock. Use only antiparasitic drugs that are Rotating pastures with other livestock effective based on recent diagnostic test results and approved for the particular species or horses. parasites present on the farm. Always follow the directions on the drug’s label. Dragging or harrowing pastures to break up manure piles. Don’t use antiparasitic drugs for unapproved uses. Keeping pasture grass sufficiently tall. Because most parasite larvae stay within 1 inch from the ground, grass Ideally, identify and cull the animals that that is too short exposes animals to are the highest fecal egg shedders. more
Recommended publications
  • Skin Probiotics ACCELERATING INNOVATION
    ACCELERATING INNOVATION James Madison University technologies are available for licensing through its nonprofit affiliate, James Madison Innovations, Inc. Skin Probiotics Inventors: Reid Harris and Kevin Minbiole Department: Biology and Chemistry Overview Research Funding and Source: National Science Foundation James Madison University inventors have filed a patent Years of Development: 4 years application on a helpful bacterium that could potentially be Technology Readiness: Research Development used as a therapy for human skin fungus such as athlete’s foot. Patent Status: U.S. patent pending 20110002891 The JMU inventors have developed a potential process to Contact: Mary Lou Bourne, Director of Technology Transfer deliver a helpful microbe, Janthinobacterium Lividum to the James Madison University skin using a pharmaceutically acceptable carrier. The microbe Phone: (540)568-2865 E-mail: [email protected] has been shown to suppress bacterial and fungal growth on animals and in lab demonstrations. Tech Transfer and Business Model Infections can be a problem for a wide array of hosts. For JMI is interested in identifying an existing company or example, there are a variety of infections, such as bacterial, entrepreneur interested in commercializing the technology viral and/or fungal infections, that affect a large percentage of either under an exclusive or a non-exclusive license. A the human population. Tricophyton rubrum, the fungus that small company or entrepreneur could further develop the causes athlete’s foot, is responsible for approximately 46% to technology, possibly using SBIR or STTR funding. 72% of cutaneous and nail mycoses worldwide. Onychomycosis, a common and persistent fungal infection, is Market and Competition In 2008, the U.S.
    [Show full text]
  • Natural Products As Potential Antiparasitic Drugs
    Natural Products as potential antiparasitic drugs OLIVER KAYSER1, ALBRECHT F. KIDERLEN2, SIMON L. CROFT3 1Freie Universität Berlin Institut für Pharmazie, Pharmazeutische Biotechnologie Kelchstraße 31, 12169 Berlin, Germany 2Robert Koch-Institut Nordufer 20 13353 Berlin, Germany 3London School of Hygiene and Tropical Medicine Department of Infectious and Tropical Diseases Keppel Street London, WC1E 7HT, United Kingdom ABSTRACT: Pharmaceutical research in natural products represents a major strategy for discovering and developing new drugs. The use of medicinal plants for the treatment of parasitic diseases is well known and documented since ancient times e.g. by the use of Cinchona succiruba (Rubiaceae) as an antimalarial. This chapter provides a comprehensive review of the latest results in the field of antiparasitic drug development from biologic sources (plants, bacteria, fungi and marine organisms) focussing on the treatment of protozoal infections (Plasmodium, Leishmania, Trypanosoma spp.). The status of validated in vitro and in vivo assays is reviewed, discussing their different features, problems and limitations. Because of the high number of natural products tested against the aforesaid protozoa in the last years, we limit the discussion to lignans, phenolics, terpenoids, and alkaloids as defined natural product classes. The review also covers essential research topics of recent publications on specific natural products (e.g. licochalcone A, benzyl- and naphthylisoquinoline alkaloids, and artemisinin) and gives an outlook to semi- synthetic approaches of drugs already introduced in clinics or in clinical trial studies. 1. INTRODUCTION The fascination of natural products, mostly as used as a preparation from a plant with known medicinal properties, goes back to ancient times. The discovery of pure compounds as active principles in plants was first described at the beginning of the 19th century, and the art of exploiting natural products has become part of the molecular sciences.
    [Show full text]
  • Antiparasitic Properties of Cardiovascular Agents Against Human Intravascular Parasite Schistosoma Mansoni
    pharmaceuticals Article Antiparasitic Properties of Cardiovascular Agents against Human Intravascular Parasite Schistosoma mansoni Raquel Porto 1, Ana C. Mengarda 1, Rayssa A. Cajas 1, Maria C. Salvadori 2 , Fernanda S. Teixeira 2 , Daniel D. R. Arcanjo 3 , Abolghasem Siyadatpanah 4, Maria de Lourdes Pereira 5 , Polrat Wilairatana 6,* and Josué de Moraes 1,* 1 Research Center for Neglected Diseases, Guarulhos University, Praça Tereza Cristina 229, São Paulo 07023-070, SP, Brazil; [email protected] (R.P.); [email protected] (A.C.M.); [email protected] (R.A.C.) 2 Institute of Physics, University of São Paulo, São Paulo 05508-060, SP, Brazil; [email protected] (M.C.S.); [email protected] (F.S.T.) 3 Department of Biophysics and Physiology, Federal University of Piaui, Teresina 64049-550, PI, Brazil; [email protected] 4 Ferdows School of Paramedical and Health, Birjand University of Medical Sciences, Birjand 9717853577, Iran; [email protected] 5 CICECO-Aveiro Institute of Materials & Department of Medical Sciences, University of Aveiro, 3810-193 Aveiro, Portugal; [email protected] 6 Department of Clinical Tropical Medicine, Faculty of Tropical Medicine, Mahidol University, Bangkok 10400, Thailand * Correspondence: [email protected] (P.W.); [email protected] (J.d.M.) Citation: Porto, R.; Mengarda, A.C.; Abstract: The intravascular parasitic worm Schistosoma mansoni is a causative agent of schistosomiasis, Cajas, R.A.; Salvadori, M.C.; Teixeira, a disease of great global public health significance. Praziquantel is the only drug available to F.S.; Arcanjo, D.D.R.; Siyadatpanah, treat schistosomiasis and there is an urgent demand for new anthelmintic agents.
    [Show full text]
  • WSAVA List of Essential Medicines for Cats and Dogs
    The World Small Animal Veterinary Association (WSAVA) List of Essential Medicines for Cats and Dogs Version 1; January 20th, 2020 Members of the WSAVA Therapeutic Guidelines Group (TGG) Steagall PV, Pelligand L, Page SW, Bourgeois M, Weese S, Manigot G, Dublin D, Ferreira JP, Guardabassi L © 2020 WSAVA All Rights Reserved Contents Background ................................................................................................................................... 2 Definition ...................................................................................................................................... 2 Using the List of Essential Medicines ............................................................................................ 2 Criteria for selection of essential medicines ................................................................................. 3 Anaesthetic, analgesic, sedative and emergency drugs ............................................................... 4 Antimicrobial drugs ....................................................................................................................... 7 Antibacterial and antiprotozoal drugs ....................................................................................... 7 Systemic administration ........................................................................................................ 7 Topical administration ........................................................................................................... 9 Antifungal drugs .....................................................................................................................
    [Show full text]
  • Antiprotozoal and Antitumor Activity of Natural Polycyclic Endoperoxides: Origin, Structures and Biological Activity
    molecules Review Antiprotozoal and Antitumor Activity of Natural Polycyclic Endoperoxides: Origin, Structures and Biological Activity Valery M. Dembitsky 1,2,*, Ekaterina Ermolenko 2, Nick Savidov 1, Tatyana A. Gloriozova 3 and Vladimir V. Poroikov 3 1 Centre for Applied Research, Innovation and Entrepreneurship, Lethbridge College, 3000 College Drive South, Lethbridge, AB T1K 1L6, Canada; [email protected] 2 A.V. Zhirmunsky National Scientific Center of Marine Biology, 17 Palchevsky Str., 690041 Vladivostok, Russia; [email protected] 3 Institute of Biomedical Chemistry, 10 Pogodinskaya Str., 119121 Moscow, Russia; [email protected] (T.A.G.); [email protected] (V.V.P.) * Correspondence: [email protected]; Tel.: +1-403-320-3202 (ext. 5463); Fax: +1-888-858-8517 Abstract: Polycyclic endoperoxides are rare natural metabolites found and isolated in plants, fungi, and marine invertebrates. The purpose of this review is a comparative analysis of the pharmacological potential of these natural products. According to PASS (Prediction of Activity Spectra for Substances) estimates, they are more likely to exhibit antiprotozoal and antitumor properties. Some of them are now widely used in clinical medicine. All polycyclic endoperoxides presented in this article demonstrate antiprotozoal activity and can be divided into three groups. The third group includes endoperoxides, which show weak antiprotozoal activity with a reliability of up to 70%, and this group includes only 1.1% of metabolites. The second group includes the largest number of endoperoxides, Citation: Dembitsky, V.M.; which are 65% and show average antiprotozoal activity with a confidence level of 70 to 90%. Lastly, Ermolenko, E.; Savidov, N.; the third group includes endoperoxides, which are 33.9% and show strong antiprotozoal activity with Gloriozova, T.A.; Poroikov, V.V.
    [Show full text]
  • The Role of Antiparasitc Drugs and Steroids in Covid-19 Treatment
    Research, Society and Development, v. 10, n. 8, e39510817300, 2021 (CC BY 4.0) | ISSN 2525-3409 | DOI: http://dx.doi.org/10.33448/rsd-v10i8.17300 The role of antiparasitc drugs and steroids in Covid-19 treatment O papel das drogas antiparasitárias e corticóides no tratamento da Covid-19 El papel de los antiparasitos y los esteroides en el tratamiento del Covid-19 Received: 06/17/2021 | Reviewed: 06/25/2021 | Accept: 07/03/2021 | Published: 07/14/2021 Luciano Barreto Filho ORCID: https://orcid.org/0000-0002-1508-4812 Faculdade de Odontologida do Recife, Brazil E-mail: [email protected] Paulo Reis Melo Júnior ORCID: https://orcid.org/0000-0001-9926-5348 Faculdade de Odontologia do Recife, Brazil E-mail: [email protected] Guilherme Marinho Sampaio ORCID: https://orcid.org/0000-0003-4441-7601 Faculdade de Odontologia do Recife, Brazil E-mail: [email protected] Gabriel Henrique Queiroz Oliveira ORCID:https://orcid.org/0000-0002-7795-3964 Faculdade de Odontologia do Recife, Brazil E-mail: [email protected] Hadassa Fonsêca Da Silva ORCID: https://orcid.org/0000-0002-9432-9522 Faculdade de Odontologia do Recife, Brazil E-mail: [email protected] Sandra Sayão Maia ORCID: https://orcid.org/0000-0001-6808-9775 Faculdade de Odontologia do Recife, Brazil E-mail: [email protected] Abstract Background: COVID-19 has emerged as a pandemic that spread throughout the world in less than 6 months, leaving hundred thousand deaths behind. Surprisingly, old drug arsenal has now been applied as an option of treatment. Objective: The aim of this article was to accomplish a literature review concerning the antiparasitic chloroquine, ivermectin, nitazoxanide; as well as glucocorticoids as possible therapeutic agents to be applied in patients with COVID-19 in Brazilian hospitals.
    [Show full text]
  • Essential Oils and Bioactive Components Against Arthritis: a Novel Perspective on Their Therapeutic Potential
    plants Review Essential Oils and Bioactive Components against Arthritis: A Novel Perspective on Their Therapeutic Potential Mariangela Marrelli * , Valentina Amodeo, Maria Rosaria Perri, Filomena Conforti y and Giancarlo Statti y Department of Pharmacy, Health and Nutritional Sciences, University of Calabria, 87036 Rende (CS), Italy; [email protected] (V.A.); [email protected] (M.R.P.); fi[email protected] (F.C.); [email protected] (G.S.) * Correspondence: [email protected]; Tel.: +39-0984-493168; Fax: +39-0984-493107 These authors jointly supervised and contributed equally to this work. y Received: 18 August 2020; Accepted: 21 September 2020; Published: 23 September 2020 Abstract: Essential oils (EOs) are known to possess a number of beneficial properties. Their antimicrobial, anti-inflammatory, antioxidant, antidiabetic, and cancer-preventing activities have been extensively reported. Due to their wide use as food preservers and additives, as well as their use in agriculture, perfumes, and make-up products, these complex mixtures of volatile compounds have gained importance from a commercial point of view, not only in the pharmaceutical industry, but also in agronomic, food, cosmetic, and perfume industries. An analysis of the recent scientific literature allowed us to highlight the presence of an increasing number of studies on the potential antiarthritic properties of EOs and their main constituents, which seems to suggest a new interesting potential therapeutic application. The aim of this review is to examine the current knowledge on the beneficial effects of essential oils in the treatment of arthritic diseases, providing an overview of the reports on the in vivo and in vitro effects of EOs.
    [Show full text]
  • Review Rheumatological Patients Undergoing Immunosuppressive
    Review Rheumatological patients undergoing immunosuppressive treatments and parasitic diseases: a review of the literature of clinical cases and perspectives to screen and follow-up active and latent chronic infections S. Fabiani and F. Bruschi Department of Translational Research ABSTRACT Conclusions. Considering parasitic in- and New Technologies in Medicine and Objective. Nowadays, several po- fections as emerging and potentially se- Surgery, School of Infectious Diseases, tent immunosuppressive drugs are rious in their evolution, additional strat- Università di Pisa, Pisa, Italy available for patients with rheumato- egies for the prevention, careful screen- Silvia Fabiani, MD logic disorders. In general, these treat- ing and follow-up, with a high level of Fabrizio Bruschi, MD ments are acceptably well tolerated. suspicion, identification, and pre-emp- Please address correspondence to: Nevertheless, in patients with rheu- tive therapy are necessary in candidate Fabrizio Bruschi, matic diseases, who are taking immu- patients for biological agents. Scuola Medica, Via Roma 55, nosuppressive drugs, an increased risk 56126 Pisa, Italy. of bacterial, viral and fungal, as well Introduction E-mail: [email protected] as parasitic infections, exists. Rationale Received on October 14, 2013; accepted Methods. We have reviewed literature, Immunosuppressive drugs, other than in revised form on February 18, 2014. on PubMed library, on the topic “par- corticosteroids (CS), are used in the Clin Exp Rheumatol 2014; 32: 587-596. asitic infections in rheumatic disease treatment of various rheumatologic con- © Copyright CLINICAL AND patients treated with immunosuppres- ditions to induce or maintain a remis- EXPERIMENTAL RHEUMATOLOGY 2014. sive drugs, including biological thera- sion, to reduce the frequency of flare pies”.
    [Show full text]
  • POS0555 the NATURAL COURSE of RHEUMATOID ARTHRITIS- Medications for RA Or for Comorbidities Including Adverse Events (Aes)
    Ann Rheum Dis: first published as 10.1136/annrheumdis-2021-eular.2810 on 19 May 2021. Downloaded from 512 Scientific Abstracts Methods: We used a large Japanese administrative claims database con- Co., Ltd., Eisai Co., Ltd., Eli Lilly Japan K.K., Pfizer Japan Inc., and Takeda structed by the Japan Medical Data Center (JMDC)2. Patients with the Inter- Pharmaceutical Co., Ltd., Consultant of: AbbVie GK, Bristol-Myers Squibb K.K., national Classification of Diseases 10th revision (ICD-10) codes for RA were Chugai Pharmaceutical Co., Ltd., Eli Lilly Japan K.K., and Gilead Sciences enrolled at the first DMARDs prescription after no DMARDs prescription period Inc., Grant/research support from: AbbVie GK, and Asahi Kasei Corp., Astellas for 6-months (index date) in the period from 1/1/2012 to 12/31/2017. Patients who Pharma Inc., Ayumi Pharmaceutical Corporation, Bristol-Myers Squibb K.K., were observable for 12 months after the index date as a follow-up period were Chugai Pharmaceutical Co., Ltd. Daiichi-Sankyo, Inc., Eisai Co., Ltd., Mitsubishi included. Patients treated with CSs within the follow-up period were compared Tanabe Pharma Corporation., Nippon Kayaku Co., Ltd., Taisho Pharmaceutical with those without them (CS and non-CS group). The primary endpoint was Co., Ltd., and Takeda Pharmaceutical Co., Ltd. mean medical cost per patient in the 12-month follow-up period. The secondary DOI: 10.1136/annrheumdis-2021-eular.2805 endpoints were costs for drugs, treatments, and materials and the proportions of patients using the subcategories of each resource. Drugs were divided into POS0555 THE NATURAL COURSE OF RHEUMATOID ARTHRITIS- medications for RA or for comorbidities including adverse events (AEs).
    [Show full text]
  • Antiparasitic, Antibacterial, and Antifungal Activities Derived from a Terminalia Catappa Solution Against Some Tilapia (Oreochromis Niloticus) Pathogens
    Antiparasitic, Antibacterial, and Antifungal Activities Derived from a Terminalia catappa Solution against Some Tilapia (Oreochromis niloticus) Pathogens C. Chitmanat, K. Tongdonmuan, P. Khanom, P. Pachontis and W. Nunsong Department of Fisheries Technology College of Agricultural Production Maejo University, Chiang Mai, 50290 Thailand Keywords: antibacterial activity, antiparasitic activity, antifungal activity, Terminalia catappa, medicinal plant, tilapia Abstract Tilapia, Oreochromis niloticus, is one of the most economically important fishery products of Thailand with export viability. Unfortunately, disease losses cause a major problem in the production of farmed tilapia. Most farmers have been using chemicals and antibiotics to treat fish pathogens which leads to the creation of antibiotic resistant pathogens and undesired residues in the fish and in the environment. Food safety is currently a great concern worldwide and Thailand’s inspectors are now finding antibiotic residues in exported fish products. The purpose of the present research is to apply the Indian almond, Terminalia catappa, as an alternative to the use of chemicals and antibiotics in the aquaculture industry. Dried leaves of Indian almond were ground and dissolved in water. A variety of concentrations of this solution were used to determine resulting activities against tilapia pathogens. The results indicated that Trichodina, fish ectoparasites, were eradicated at 800 ppm. The growth of two strains of Aeromonas hydrophila was also inhibited at a concentration of 0.5 mg/ml Indian almond leaves upward. In addition, this solution can reduce the fungal infection in tilapia eggs. Research is underway to determine the toxicity of this solution, if any, on tilapia and the isolation of the active ingredients in the Indian almond for fish pathogen treatment.
    [Show full text]
  • Antiviral Activity of Ivermectin Against SARS-Cov-2: an Old-Fashioned Dog with a New Trick— a Literature Review
    Scientia Pharmaceutica Review Antiviral Activity of Ivermectin Against SARS-CoV-2: An Old-Fashioned Dog with a New Trick— A Literature Review Mudatsir Mudatsir 1,2,3,* , Amanda Yufika 2,4 , Firzan Nainu 5, Andri Frediansyah 6,7 , Dewi Megawati 8,9, Agung Pranata 2,3,10 , Wilda Mahdani 1,2,3, Ichsan Ichsan 1,2,3, Kuldeep Dhama 11 and Harapan Harapan 1,2,3,* 1 Department of Microbiology, School of Medicine, Universitas Syiah Kuala, Banda Aceh, Aceh 2311, Indonesia; [email protected] (W.M.); [email protected] (I.I.) 2 Medical Research Unit, School of Medicine, Universitas Syiah Kuala, Banda Aceh, Aceh 23111, Indonesia; amandayufi[email protected] (A.Y.); [email protected] (A.P.) 3 Tropical Disease Centre, School of Medicine, Universitas Syiah Kuala, Banda Aceh, Aceh 23111, Indonesia 4 Department of Family Medicine, School of Medicine, Universitas Syiah Kuala, Banda Aceh, Aceh 23111, Indonesia 5 Faculty of Pharmacy, Hasanuddin University, Makassar 90245, Indonesia; fi[email protected] 6 Research Division for Natural Product Technology (BPTBA), Indonesian Institute of Sciences (LIPI), Wonosari 55861, Indonesia; [email protected] 7 Department of Pharmaceutical Biology, Pharmaceutical Institute, University of Tübingen, 72076 Tübingen, Germany 8 Department of Microbiology and Parasitology, Faculty of Medicine and Health Sciences, Warmadewa University, Denpasar 80239, Indonesia; [email protected] 9 Department of Medical Microbiology and Immunology, School of Medicine, University of California, Davis, California, CA 95616, USA 10 Department of Parasitology, School of Medicine, Universitas Syiah Kuala, Banda Aceh, Aceh 23111, Indonesia 11 Division of Pathology, ICAR-Indian Veterinary Research Institute, Izatnagar, Bareilly, Uttar Pradesh 243122, India; kdhama@rediffmail.com * Correspondence: [email protected] (M.M.); [email protected] (H.H.) Received: 20 July 2020; Accepted: 10 August 2020; Published: 17 August 2020 Abstract: The coronavirus disease 2019 (COVID-19) pandemic is a major global threat.
    [Show full text]
  • Parasiticides: Fenbendazole, Ivermectin, Moxidectin Livestock
    Parasiticides: Fenbendazole, Ivermectin, Moxidectin Livestock 1 Identification of Petitioned Substance* 2 3 Chemical Names: 48 Ivermectin: Heart Guard, Sklice, Stomectol, 4 Moxidectin:(1'R,2R,4Z,4'S,5S,6S,8'R,10'E,13'R,14'E 49 Ivomec, Mectizan, Ivexterm, Scabo 6 5 ,16'E,20'R,21'R,24'S)-21',24'-Dihydroxy-4 50 Thiabendazole: Mintezol, Tresaderm, Arbotect 6 (methoxyimino)-5,11',13',22'-tetramethyl-6-[(2E)- 51 Albendazole: Albenza 7 4-methyl-2-penten-2-yl]-3,4,5,6-tetrahydro-2'H- 52 Levamisole: Ergamisol 8 spiro[pyran-2,6'-[3,7,1 9]trioxatetracyclo 53 Morantel tartrate: Rumatel 9 [15.6.1.14,8.020,24] pentacosa[10,14,16,22] tetraen]- 54 Pyrantel: Banminth, Antiminth, Cobantril 10 2'-one; (2aE, 4E,5’R,6R,6’S,8E,11R,13S,- 55 Doramectin: Dectomax 11 15S,17aR,20R,20aR,20bS)-6’-[(E)-1,2-Dimethyl-1- 56 Eprinomectin: Ivomec, Longrange 12 butenyl]-5’,6,6’,7,10,11,14,15,17a,20,20a,20b- 57 Piperazine: Wazine, Pig Wormer 13 dodecahydro-20,20b-dihydroxy-5’6,8,19-tetra- 58 14 methylspiro[11,15-methano-2H,13H,17H- CAS Numbers: 113507-06-5; 15 furo[4,3,2-pq][2,6]benzodioxacylooctadecin-13,2’- Moxidectin: 16 [2H]pyrano]-4’,17(3’H)-dione,4’-(E)-(O- Fenbendazole: 43210-67-9; 70288-86-7 17 methyloxime) Ivermectin: 59 Thiabendazole: 148-79-8 18 Fenbendazole: methyl N-(6-phenylsulfanyl-1H- 60 Albendazole: 54965-21-8 19 benzimidazol-2-yl) carbamate 61 Levamisole: 14769-72-4 20 Ivermectin: 22,23-dihydroavermectin B1a +22,23- 21 dihydroavermectin B1b 62 Morantel tartrate: 26155-31-7 63 Pyrantel: 22204-24-6 22 Thiabendazole: 4-(1H-1,3-benzodiazol-2-yl)-1,3- 23 thiazole
    [Show full text]